The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Timing of Complications in Percutaneous Renal Biopsy
Abstract
Percutaneous renal biopsy (PRB) is a safe and effective tool in the diagnosis and management of renal disease; however, the optimal timing of observation after biopsy is not clearly established. With the use of real-time ultrasound guidance, PRB of native kidneys was performed in 750 adult patients at an academic institution by an attending nephrologist or fellow between June 1983 and June 2002. All patients were observed for 23 to 24 h after biopsy for the presence, severity, and timing of complications. Biopsy-related complications occurred in 98 (13%) patients; minor complications occurred in 50 (6.6%) patients, and major complications occurred in 48 (6.4%) patients. One (0.1%) patient died as a result of the biopsy. Multivariate analysis using logistic regression found only serum creatinine at baseline predictive of a complication. Patients with a serum creatinine > or = 5.0 mg/dl were 2.3 times as likely to have a complication (odds ratio, 2.3; 95% confidence interval, 1.3 to 4.1; P < 0.005). Complications were identified in 38 (42%) patients by < or = 4 h, in 61 (67%) patients by < or = 8 h, in 77 (85%) patients by < or = 12 h, and in 81 (89%) patients at < or = 24 h. The PRB remains a safe procedure, but the risk of complication is higher in patients with advanced renal insufficiency. After biopsy, an observation time of up to 24 h remains optimal as an observation period of < or = 8 h risks missing > or = 33% of complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korbet, S. M. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.31713 · Cited by 205
Self-citationNicholson, M. L., Wheatley, T. J., Doughman, T. M., White, S. A., Morgan, J. D. T., Veitch, P. S., & Furness, P. N. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00177.x · Cited by 168
Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys
Mendelssohn, D. C., & Cole, E. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90592-8 · Cited by 133
Winkelmayer, W. C., Levin, R., & Avorn, J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50026 · Cited by 72
Cited by
Guidelines for the use of platelet transfusions
Estcourt, L. J., Birchall, J., Allard, S., Bassey, S. J., Hersey, P., Kerr, J. P., Mumford, A. D., Stanworth, S. J., Tinegate, H., & the British Committee for Standards in Haematology (2017) · British Journal of Haematology · doi:10.1111/bjh.14423 · Cited by 648
Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-analysis
Corapi, K. M., Chen, J. L. T., Balk, E. M., & Gordon, C. E. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.330 · Cited by 436
Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis
Boulware, L. E., Jaar, B. G., Tarver-Carr, M. E., Brancati, F. L., & Powe, N. R. (2003) · JAMA · doi:10.1001/jama.290.23.3101 · Cited by 381
Quality Improvement Guidelines for Percutaneous Needle Biopsy
Gupta, S., Wallace, M. J., Cardella, J. F., Kundu, S., Miller, D. L., & Rose, S. C. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.01.011 · Cited by 345
Lucas, G. M., Ross, M. J., Stock, P. G., Shlipak, M. G., Wyatt, C. M., Gupta, S. K., Atta, M. G., Wools-Kaloustian, K. K., Pham, P. A., Bruggeman, L. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu617 · Cited by 310
Metadata
- Authors
- Whittier, W. L., & Korbet, S. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2004-01
- Volume
- 15
- Issue
- 1
- Pages
- 142-147
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2146595067
- Cited by
- 454
- References
- 4
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Timing of Complications in Percutaneous Renal Biopsy. https://app.cochat.ai/papers/10.1097/01.asn.0000102472.37947.14
- The paper
- Whittier, W. L., & Korbet, S. M. (2004). Timing of Complications in Percutaneous Renal Biopsy. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000102472.37947.14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.